Get started
Award

R21-HL091368

Funded outputs count: 7
Funder award ID: R21-HL091368
OpenAlex ID: G779460750
Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy
2016 · Kassandra S. Thomson, Guy L. Odom, et al. · JACC Basic to Translational Science · 17
PDF
Cardiac Myosin Activation with Gene Therapy Produces Sustained Inotropic Effects and May Treat Heart Failure with Reduced Ejection Fraction
2016 · Sam L. Teichman, Kassandra S. Thomson, et al. · Handbook of experimental pharmacology · 5
Cell-based delivery of dATP via gap junctions enhances cardiac contractility
2014 · Scott D. Lundy, Sean A. Murphy, et al. · Journal of Molecular and Cellular Cardiology · 22
Thin filament incorporation of an engineered cardiac troponin C variant (L48Q) enhances contractility in intact cardiomyocytes from healthy and infarcted hearts
2014 · Erik R. Feest, F. Steven Korte, et al. · Journal of Molecular and Cellular Cardiology · 25
Transgenic overexpression of ribonucleotide reductase improves cardiac performance
2013 · Sarah G. Nowakowski, Stephen C. Kolwicz, et al. · Proceedings of the National Academy of Sciences · 45
PDF
Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
2013 · Scott D. Lundy, Wei-Zhong Zhu, et al. · Stem Cells and Development · 734
Upregulation of cardiomyocyte ribonucleotide reductase increases intracellular 2 deoxy-ATP, contractility, and relaxation
2011 · F.S. Korte, Jin Dai, et al. · Journal of Molecular and Cellular Cardiology · 48
PDF
Year
Topic